Zejing Pharmaceuticals (688266.SH): Injection ZG006 used to treat neuroendocrine tumors receives FDA orphan drug designation.

Wisdom Finance APP News, Zejing Pharmaceutical (688266.SH) announced that the company's investigational product ZG006 for injection has received orphan drug designation from the Food and Drug Administration ("FDA") of the United States, for the treatment of neuroendocrine tumors.